Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders

Yisu Gu; Lise J Estcourt; Carolyn Doree; Marialena Trivella; Sally Hopewell; Paresh Vyas

doi:10.1002/14651858.CD011577

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders

Cochrane Database Syst Rev. 2015 Mar 11:3:CD011577. doi: 10.1002/14651858.CD011577.

Authors

Yisu Gu¹, Lise J Estcourt², Carolyn Doree³, Marialena Trivella⁴, Sally Hopewell⁴, Paresh Vyas⁵

Affiliations

¹ Haematology, NHS/ University of Oxford, Oxford, UK.
² Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
³ Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
⁴ Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
⁵ MRC Molecular Haematology Unit and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of a restrictive versus liberal red cell transfusion strategy for patients with long-term bone marrow failure. These include myelodysplasia, acquired aplastic anaemia, and other inherited bone marrow failure disorders.

Publication types

Research Support, Non-U.S. Gov't

Abstract

Publication types

Grants and funding